This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fohlmeister J, Fischer R, Modder B, Rister M, Schaefer ME . Aplastic anemia and hypocellular myelodysplatic syndrome: histomorphological, diagnostic and prognostic features J Clin Pathol 1985 38: 1218–1224
Tuzuner N, Cox C, Rowe JM, Watrous D, Bennet JM . Hypocellular myelodysplastic syndrome (MDS): new proposals Br J Haematol 1995 91: 612–617
Appelbaum FR, Barral J, Storb R, Ramberg R, Doney K, Sale GE, Thomas ED . Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia Exp Hematol 1987 15: 1134–1139
ISCN (1995) Mitelman F (ed). An International System for Human Cytogenetic Nomenclature S Karger:Basel 1995
Dewald GW, Schad CR, Christensen ER, Law ME, Zinsmeister AR, Stalboerger PG, Jalal SM, Ash RC, Jenkins RB . Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation Bone Marrow Transplant 1993 12: 149–154
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bernasconi, P., Astori, C., Cavigliano, P. et al. Cytogenetic and FISH analysis in five patients with hypoplastic bone marrow. Leukemia 14, 1322–1323 (2000). https://doi.org/10.1038/sj.leu.2401827
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401827
This article is cited by
-
Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome
Leukemia (2005)
-
Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients
Leukemia (2003)
-
Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea
Leukemia (2002)